Evaluating the Efficacy and Safety of Bemcentinib in Patients With Myelodysplastic Syndromes

Clinical trial NCT03824080 · COMPLETED

Trial details

NCT number: NCT03824080
Sponsor: GWT-TUD GmbH
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia High-risk Myelodysplastic Syndrome Low-risk Myelodysplastic Syndrome

Start date: 2018-12-20
Primary completion: 2020-07-13
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.